Source: CNBCView original →
Additive ManufacturingJuly 22, 2026
Trump plans generic drug tariffs from 2028 with two-year delay testing U.S. onshoring push
Summary
Trump plans to impose tariffs on generic drugs starting in 2028, with a two-year delay before implementation. The headline frames the delay as a test of the U.S. push to reshore production.
Why It Matters
For operators, the delayed start would make sourcing decisions, supplier contracts, and domestic capacity planning more time-sensitive. Investors would watch whether the tariff timeline creates enough pressure to support U.S. generic drug manufacturing, while supply chains would need to assess exposure to imported products before the policy takes effect.